Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Assunto: FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEZANI, Thaisa Marinho et al. Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: a study with antiretroviral drugs. European Journal of Pharmaceutics and Biopharmaceutics, v. 104, p. 131-139, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2016.04.020. Acesso em: 13 out. 2024.APA
Dezani, T. M., Dezani, A. B., Silva Junior, J. B. da, & Serra, C. H. dos R. (2016). Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: a study with antiretroviral drugs. European Journal of Pharmaceutics and Biopharmaceutics, 104, 131-139. doi:10.1016/j.ejpb.2016.04.020NLM
Dezani TM, Dezani AB, Silva Junior JB da, Serra CH dos R. Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: a study with antiretroviral drugs [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 104 131-139.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.ejpb.2016.04.020Vancouver
Dezani TM, Dezani AB, Silva Junior JB da, Serra CH dos R. Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: a study with antiretroviral drugs [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 104 131-139.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.ejpb.2016.04.020